-
Trader’s Watch List: Bristol-Myers Squibb Company (NYSE:BMY), BIND Therapeutics (NASDAQ:BIND), Medifast Inc. (NYSE:MED), LightInTheBox Holding Co., (NYSE:LITB), The Boeing (NYSE:BA)
On Tuesday shares of Bristol-Myers Squibb Company (NYSE:BMY) closed at $67.62. Company’s sales growth for last 5 years was -3.30% and EPS growth for next 5 years is recorded as 16.21%. A California judge on Tuesday tentatively tossed three relators from the whistleblower suit they brought alleging Bristol-Myers Squibb Company (NYSE:BMY) violated California’ insurance fraud […]
-
Fast Moving Stocks: Nektar Therapeutics (NASDAQ:NKTR), BIND Therapeutics (NASDAQ:BIND), Taylor Devices Inc. (NASDAQ:TAYD), First Solar (NASDAQ:FSLR), Cognizant Technology Solutions (NASDAQ:CTSH)
On Monday shares of Nektar Therapeutics (NASDAQ:NKTR) closed at $14.07. Company’s sales growth for last 5 years was 22.80% and EPS growth for next 5 years is recorded as 42.50%. JPMorgan Chase & Co. set a $19.00 target price on Nektar Therapeutics (NASDAQ:NKTR) in a report issued on Friday. The firm currently has a buy […]
-
Active Movers: ATRION Corp. (NASDAQ:ATRI), BIND Therapeutics (NASDAQ:BIND), DragonWave Inc. (NASDAQ:DRWI), Lennar Corp. (NYSE:LEN), Fuel-Tech (NASDAQ:FTEK)
Atrion Corp (NASDAQ: ATRI) declared a quarterly dividend of $0.75 per share, or $3 annualized. The dividend will be payable on March 31, 2015, to stockholders of record on March 17, 2015, with an ex-dividend date of March 13, 2015. On Wednesday shares of ATRION Corp. (NASDAQ:ATRI) closed at $322.43. Company’s sales growth for last […]
-
Keep Eyes on: Active Power Inc. (NASDAQ:ACPW), BIND Therapeutics (NASDAQ:BIND), DragonWave Inc. (NASDAQ:DRWI), LyondellBasell Industries N.V. (NYSE:LYB), Endocyte (NASDAQ:ECYT)
Active Power, Inc. (NASDAQ: ACPW), has been invited to present at the 27th Annual ROTH Conference being held March 8-11, 2015, at the Ritz Carlton in Dana Point, Calif. On Monday shares of Active Power Inc. (NASDAQ:ACPW) closed at $2.13. Company’s sales growth for last 5 years was 7.50% and EPS growth for next 5 […]
-
Don’t Miss These Stocks: BIND Therapeutics (NASDAQ:BIND), Sprouts Farmers Market (NASDAQ:SFM), Liberty Media NASDAQ:LMCA), Signal Genetics (NASDAQ:SGNL), Mastech Holdings (NYSEMKT:MHH)
BIND Therapeutics, Inc. (NASDAQ:BIND), announced that Andrew Hirsch, BIND’s chief operating officer and chief financial officer, will present at the Cowen & Co. 35th Annual Healthcare Conference in Boston on Tuesday, March 3, 2015 at 10:40 a.m. ET. On Wednesday shares of BIND Therapeutics, Inc. (NASDAQ:BIND) closed at $6.29. Sprouts Farmers Market (NASDAQ: SFM) reported […]
-
What’s Hot: BIND Therapeutics (NASDAQ:BIND), ConocoPhillips (NYSE:COP), Nortek Inc. (NASDAQ:NTK), Resolute Forest Products Inc. (NYSE:RFP), SUPERVALU Inc. (NYSE:SVU)
BIND Therapeutics, Inc. (NASDAQ:BIND), announced that Andrew Hirsch, BIND’s chief operating officer and chief financial officer, will present at the Cowen & Co. 35th Annual Healthcare Conference in Boston on Tuesday, March 3, 2015 at 10:40 a.m. ET. On Thursday shares of BIND Therapeutics, Inc. (NASDAQ:BIND) closed at $6.64. ConocoPhillips (NYSE:COP) had its price objective […]
-
Watch 5 Stocks: BIND Therapeutics (NASDAQ:BIND), LifeLock (NYSE:LOCK), Universal Corporation (NYSE:UVV), New York Community Bancorp Inc. (NYSE:NYCB), NVE Corp. (NASDAQ:NVEC)
On February 5, 2015, BIND Therapeutics, Inc. (NASDAQ:BIND) entered into an underwriting agreement with Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several underwriters named therein in connection with the public offering, issuance and sale by the Company of 3,739,130 shares of the Company’s common stock, par value $0.0001 […]
-
Healthcare Decliners: Immunomedics Inc. (NASDAQ:IMMU), OraSure Technologies (NASDAQ:OSUR), BIND Therapeutics (NASDAQ:BIND), Nexvet Biopharma PLC (NASDAQ:NVET), AxoGen (NASDAQ:AXGN)
Immunomedics, Inc., (NASDAQ:IMMU) announced the pricing of its offering of $85,000,000 aggregate principal amount of 4.75% Convertible Senior Notes due 2020 (the “Convertible Notes”) in a private placement under the Securities Act of 1933, as amended (the “Securities Act”). Immunomedics also granted the initial purchasers of the Convertible Notes a 30-day option to purchase up […]
-
Biotech Losers: Immunomedics Inc. (NASDAQ:IMMU), BIND Therapeutics (NASDAQ:BIND), Nexvet Biopharma PLC (NASDAQ:NVET), Egalet Corporation (NASDAQ:EGLT), Atara Biotherapeutics (NASDAQ:ATRA)
Immunomedics Inc. (NASDAQ:IMMU) reported a loss of $11.4 million in its fiscal second quarter. The Morris Plains, New Jersey-based company said it had a loss of 12 cents per share. The results topped Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share. […]